Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Germany passes law on stem cell research

This article was originally published in Clinica

Executive Summary

The decision by the German lower house (Bundestag) last week to allow the restricted import of embryonic stem cells for research purposes has been welcomed by the biotech industry. The move means that MPs have now voted into law the proposals debated in January by a majority of 360 for to 190 compared with 340 for to 265 against during the previous debate (see Clinica No 994, p 5). Three proposed amendments to the law, aimed at either introducing stricter or more relaxed regulations, were defeated.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT066301

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel